{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:14:31Z","timestamp":1790018071737,"version":"4.0.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":168,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05980-z","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:44:09Z","timestamp":1781819049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting Neuroinflammation in Adult Ischemic Stroke: Direct Immunotherapy, Regenerative Cell-Based Strategies, and Translational Challenges\u2014A Systematic Review with Exploratory Meta-analysis"],"prefix":"10.1007","volume":"63","author":[{"given":"J\u00falia","family":"Cera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wirginia","family":"Krzy\u015bciak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"5","key":"5980_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00415-025-13082-4","volume":"272","author":"M He","year":"2025","unstructured":"He M, Jaillard S, Liu X, He Y, Gu X, Yue C (2025) Global, regional, and national epidemiology of ischemic stroke in young adults, 1990\u20132021. J Neurol 272(5):354","journal-title":"J Neurol"},{"issue":"4","key":"5980_CR2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s13311-016-0483-x","volume":"13","author":"J Anrather","year":"2016","unstructured":"Anrather J, Iadecola C (2016) Inflammation and stroke: an overview. Neurotherapeutics 13(4):661\u2013670","journal-title":"Neurotherapeutics"},{"issue":"1","key":"5980_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/cns.13561","volume":"27","author":"L Wang","year":"2021","unstructured":"Wang L, Xiong X, Zhang L, Shen J (2021) Neurovascular unit: a critical role in ischemic stroke. CNS Neurosci Ther 27(1):7\u201316","journal-title":"CNS Neurosci Ther"},{"issue":"3\u20134","key":"5980_CR4","first-page":"185","volume":"1","author":"M Nour","year":"2013","unstructured":"Nour M, Scalzo F, Liebeskind DS (2013) Ischemia-reperfusion injury in stroke. Interv Neurol 1(3\u20134):185\u2013199","journal-title":"Interv Neurol"},{"issue":"8","key":"5980_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41582-019-0221-1","volume":"15","author":"G Stoll","year":"2019","unstructured":"Stoll G, Nieswandt B (2019) Thrombo-inflammation in acute ischaemic stroke: implications for treatment. Nat Rev Neurol 15(8):473\u2013481","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"5980_CR6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nm.2399","volume":"17","author":"C Iadecola","year":"2011","unstructured":"Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17(7):796\u2013808","journal-title":"Nat Med"},{"issue":"6","key":"5980_CR7","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.14336\/AD.2023.0505","volume":"14","author":"H Ma","year":"2023","unstructured":"Ma H, Li H, Zhang Y, Zhou Y, Liu H, Xu H et al (2023) Microglia exhibit distinct heterogeneity rather than M1\/M2 polarization within the early stage of acute ischemic stroke. Aging Dis 14(6):2284\u20132302","journal-title":"Aging Dis"},{"issue":"5","key":"5980_CR8","doi-asserted-by":"publisher","DOI":"10.31083\/FBL26614","volume":"30","author":"M Liu","year":"2025","unstructured":"Liu M, Fan X, Chen D, Yao H, Huang Z, Li H et al (2025) FCGR1A alleviates ischemic stroke-induced injury by promoting anti-inflammatory microglial polarization via the AMPK-mTOR signaling pathway. Front Biosci (Landmark Ed) 30(5):26614","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"11","key":"5980_CR9","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1161\/STROKEAHA.110.608257","volume":"42","author":"Y Yang","year":"2011","unstructured":"Yang Y, Rosenberg GA (2011) Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42(11):3323\u20133328","journal-title":"Stroke"},{"issue":"5","key":"5980_CR10","first-page":"2006","volume":"21","author":"CT Jiang","year":"2020","unstructured":"Jiang CT, Wu WF, Deng YH, Ge JW (2020) Modulators of microglia activation and polarization in ischemic stroke. Mol Med Rep 21(5):2006\u20132018","journal-title":"Mol Med Rep"},{"issue":"1","key":"5980_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1152\/physrev.00039.2016","volume":"98","author":"R Dantzer","year":"2018","unstructured":"Dantzer R (2018) Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol Rev 98(1):477\u2013504","journal-title":"Physiol Rev"},{"issue":"9","key":"5980_CR12","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1161\/STROKEAHA.118.021474","volume":"49","author":"AM Planas","year":"2018","unstructured":"Planas AM (2018) Role of immune cells migrating to the ischemic brain. Stroke 49(9):2261\u20132267","journal-title":"Stroke"},{"issue":"11","key":"5980_CR13","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S1474-4422(19)30078-X","volume":"18","author":"K Shi","year":"2019","unstructured":"Shi K, Tian DC, Li ZG, Ducruet AF, Lawton MT, Shi FD (2019) Global brain inflammation in stroke. Lancet Neurol 18(11):1058\u20131066","journal-title":"Lancet Neurol"},{"key":"5980_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fncel.2015.00461","volume":"9","author":"K M\u00f6ller","year":"2015","unstructured":"M\u00f6ller K, P\u00f6sel C, Kranz A, Schulz I, Scheibe J, Didwischus N, Boltze J, Weise G, et al. (2015) Arterial hypertension aggravates innate immune responses after experimental stroke. Front Cell Neurosci 9:461","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"5980_CR15","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/HYP.0000000000000053","volume":"68","author":"C Iadecola","year":"2016","unstructured":"Iadecola C, Yaffe K, Biller J, Bratzke LC, Faraci FM, Gorelick PB, Gulati M, Kamel H, et al. (2016) Impact of hypertension on cognitive function: a scientific statement from the American Heart Association. Hypertension 68(6):e67\u2013e94","journal-title":"Hypertension"},{"issue":"3","key":"5980_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/STROKEAHA.125.052147","volume":"57","author":"SI Savitz","year":"2026","unstructured":"Savitz SI, Samaniego EA, Liebeskind DS, Boltze J, STAIR XIII Participants (2026) Updated priorities for cerebroprotection trials. Stroke 57(3):829\u2013836. https:\/\/doi.org\/10.1161\/STROKEAHA.125.052147","journal-title":"Stroke"},{"issue":"12","key":"5980_CR17","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1161\/STROKEAHA.123.044279","volume":"54","author":"LR Wechsler","year":"2023","unstructured":"Wechsler LR, Adeoye O, Alemseged F, Bahr-Hosseini M, Deljkich E, Favilla C, Fisher M, Grotta J, et al. (2023) Most promising approaches to improve stroke outcomes: the Stroke Treatment Academic Industry Roundtable XII Workshop. Stroke 54(12):3202\u20133213","journal-title":"Stroke"},{"issue":"18","key":"5980_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202517043","volume":"13","author":"J Boltze","year":"2026","unstructured":"Boltze J, Fisher M (2026) Cytoprotection concepts for ischemic stroke in the recanalization era. Adv Sci (Weinh) 13(18):e17043","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"5980_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, et al. (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med 18(3):e1003583","journal-title":"PLoS Med"},{"key":"5980_CR20","first-page":"359","volume":"2006","author":"X Huang","year":"2006","unstructured":"Huang X, Lin J, Demner-Fushman D (2006) Evaluation of PICO as a knowledge representation for clinical questions. AMIA Annu Symp Proc 2006:359\u2013363","journal-title":"AMIA Annu Symp Proc"},{"issue":"3","key":"5980_CR21","doi-asserted-by":"publisher","first-page":"A12","DOI":"10.7326\/ACPJC-1995-123-3-A12","volume":"123","author":"WS Richardson","year":"1995","unstructured":"Richardson WS, Wilson MC, Nishikawa J, Hayward RS (1995) The well-built clinical question: a key to evidence-based decisions. ACP J Club 123(3):A12\u2013A13","journal-title":"ACP J Club"},{"key":"5980_CR22","unstructured":"Veltkamp R, Bhogal P (2019) Immunotherapy in ischemic stroke. In: Naidech J, Ziai W (eds) Neurocritical care informatics. Springer, Cham, pp 137\u2013151"},{"issue":"5","key":"5980_CR23","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1161\/STROKEAHA.118.020750","volume":"49","author":"CJ Smith","year":"2018","unstructured":"Smith CJ, Hulme S, Vail A, Sherrington C, Rothwell NJ, King AT et al (2018) SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke). Stroke 49(5):1210\u20131216","journal-title":"Stroke"},{"issue":"8","key":"5980_CR24","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1182\/blood.2021012322","volume":"139","author":"N Dhanesha","year":"2022","unstructured":"Dhanesha N, Patel RB, Doddapattar P, Ghatge M, Flora GD, Jain M, Thedens D, Olalde H et al (2022) PKM2 promotes neutrophil activation and cerebral thromboinflammation: therapeutic implications for ischemic stroke. Blood 139(8):1234\u20131245","journal-title":"Blood"},{"issue":"2","key":"5980_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1001\/jamaneurol.2023.5200","volume":"81","author":"K Houkin","year":"2024","unstructured":"Houkin K, Osanai T, Uchiyama S, Minematsu K, Taguchi A, Maruichi K, Niiya Y, Asaoka K, et al. (2024) Allogeneic stem cell therapy for acute ischemic stroke: the phase 2\/3 TREASURE Randomized Clinical Trial. JAMA Neurol 81(2):154\u2013162","journal-title":"JAMA Neurol"},{"key":"5980_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647","volume":"349","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 349:g7647","journal-title":"BMJ"},{"key":"5980_CR27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13287-022-02883-3","volume":"13","author":"L Xiao","year":"2022","unstructured":"Xiao L, Zheng H, Li J, Wang Q, Sun H (2022) Mesenchymal stem cell-based therapy in ischemic stroke: a systematic review and meta-analysis of preclinical studies. Stem Cell Res Ther 13:203","journal-title":"Stem Cell Res Ther"},{"key":"5980_CR28","first-page":"1123456","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Liu J, Wang M, Chen G (2023) Immunomodulatory strategies for ischemic stroke: a systematic review of clinical and translational evidence (2018\u20132022). Front Neurol 14:1123456","journal-title":"Front Neurol"},{"key":"5980_CR29","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ et al (eds) (2023) Cochrane handbook for systematic reviews of interventions. Version 6.4. Cochrane"},{"key":"5980_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"5980_CR31","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M et al (2014) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute, Ottawa. [cited 2026 Jan 18]"},{"key":"5980_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:43","journal-title":"BMC Med Res Methodol"},{"key":"5980_CR33","unstructured":"Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M et al (2006) Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC Methods Programme. Lancaster University, Lancaster. [cited 2026 Jan 18]"},{"issue":"15","key":"5980_CR34","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283(15):2008\u20132012","journal-title":"JAMA"},{"issue":"3","key":"5980_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S1474-4422(16)30357-X","volume":"16","author":"J Elkins","year":"2017","unstructured":"Elkins J, Veltkamp R, Montaner J, Johnston SC, Singhal AB, Becker K et al (2017) Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol 16(3):217\u2013226","journal-title":"Lancet Neurol"},{"issue":"8","key":"5980_CR36","doi-asserted-by":"publisher","first-page":"e1091","DOI":"10.1212\/WNL.0000000000010038","volume":"95","author":"MSV Elkind","year":"2020","unstructured":"Elkind MSV, Veltkamp R, Montaner J, Johnston SC, Singhal AB, Becker K et al (2020) Natalizumab in acute ischemic stroke (ACTION II): a randomized, placebo-controlled trial. Neurology 95(8):e1091\u2013e1104","journal-title":"Neurology"},{"issue":"7","key":"5980_CR37","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1161\/STROKEAHA.116.012995","volume":"47","author":"GK Steinberg","year":"2016","unstructured":"Steinberg GK, Kondziolka D, Wechsler LR, Lunsford LD, Coburn ML, Billigen JB et al (2016) Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1\/2a study. Stroke 47(7):1817\u20131824","journal-title":"Stroke"},{"issue":"5","key":"5980_CR38","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3171\/2018.5.JNS173147","volume":"131","author":"GK Steinberg","year":"2018","unstructured":"Steinberg GK, Kondziolka D, Wechsler LR, Lunsford LD, Kim AS, Johnson JN et al (2018) Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623): a phase 1\/2a study. J Neurosurg 131(5):1462\u20131472","journal-title":"J Neurosurg"},{"issue":"1","key":"5980_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20(1):37\u201346","journal-title":"Educ Psychol Meas"},{"issue":"2","key":"5980_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1(2):97\u2013111","journal-title":"Res Synth Methods"},{"issue":"3","key":"5980_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188","journal-title":"Control Clin Trials"},{"key":"5980_CR42","unstructured":"The Cochrane Collaboration (2020) Review Manager (RevMan) [computer program]. Version 5.4. The Cochrane Collaboration, London"},{"issue":"12","key":"5980_CR43","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/sim.791","volume":"20","author":"J Hartung","year":"2001","unstructured":"Hartung J, Knapp G (2001) On tests of the overall treatment effect in meta-analysis with normally distributed responses. Stat Med 20(12):1771\u20131782","journal-title":"Stat Med"},{"issue":"21","key":"5980_CR44","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1002\/sim.1262","volume":"21","author":"K Sidik","year":"2002","unstructured":"Sidik K, Jonkman JN (2002) A simple confidence interval for meta-analysis. Stat Med 21(21):3153\u20133159","journal-title":"Stat Med"},{"key":"5980_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-14-25","volume":"14","author":"J IntHout","year":"2014","unstructured":"IntHout J, Ioannidis JPA, Borm GF (2014) The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol 14:25","journal-title":"BMC Med Res Methodol"},{"key":"5980_CR46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12874-015-0091-1","volume":"15","author":"C R\u00f6ver","year":"2015","unstructured":"R\u00f6ver C, Knapp G, Friede T (2015) Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies. BMC Med Res Methodol 15:99","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"5980_CR47","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539\u20131558","journal-title":"Stat Med"},{"issue":"1","key":"5980_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/sim.2514","volume":"26","author":"W Viechtbauer","year":"2007","unstructured":"Viechtbauer W (2007) Confidence intervals for the amount of heterogeneity in meta-analysis. Stat Med 26(1):37\u201352","journal-title":"Stat Med"},{"issue":"2","key":"5980_CR49","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jrsm.11","volume":"1","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W, Cheung MWL (2010) Outlier and influence diagnostics for meta-analysis. Res Synth Methods 1(2):112\u2013125","journal-title":"Res Synth Methods"},{"issue":"1","key":"5980_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT (2021) Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods 12(1):55\u201361","journal-title":"Res Synth Methods"},{"key":"5980_CR51","doi-asserted-by":"publisher","DOI":"10.4159\/9780674040243","volume-title":"Summing up: the science of reviewing research","author":"RJ Light","year":"1984","unstructured":"Light RJ, Pillemer DB (1984) Summing up: the science of reviewing research. Harvard University Press, Cambridge"},{"issue":"7109","key":"5980_CR52","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629\u2013634","journal-title":"BMJ"},{"key":"5980_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JAC Sterne","year":"2011","unstructured":"Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343:d4002","journal-title":"BMJ"},{"issue":"12","key":"5980_CR54","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J et al (2011) GRADE guidelines: 5. Rating the quality of evidence - publication bias. J Clin Epidemiol 64(12):1277\u20131282","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"5980_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3102\/10769986006002107","volume":"6","author":"LV Hedges","year":"1981","unstructured":"Hedges LV (1981) Distribution theory for Glass\u2019s estimator of effect size and related estimators. J Educ Stat 6(2):107\u2013128","journal-title":"J Educ Stat"},{"key":"5980_CR56","unstructured":"R Core Team (2024) R: a language and environment for statistical computing [computer program]. Vienna: R Foundation for Statistical Computing. Available from: https:\/\/www.R-project.org\/"},{"issue":"3","key":"5980_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1\u201348","journal-title":"J Stat Softw"},{"issue":"4","key":"5980_CR58","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22(4):153\u2013160","journal-title":"Evid Based Ment Health"},{"key":"5980_CR59","unstructured":"Viechtbauer W (2024) Forest plot in RevMan style. The metafor package. [cited 2026 Jan 18]. Available from: https:\/\/www.metafor-project.org"},{"issue":"5","key":"5980_CR60","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s12975-020-00787-z","volume":"11","author":"A Jaillard","year":"2020","unstructured":"Jaillard A, Hommel M, Moisan A, Zeffiro TA, Favre-Wiki IM, Barbieux-Guillot M et al (2020) Autologous mesenchymal stem cells improve motor recovery in subacute ischemic stroke: a randomized clinical trial. Transl Stroke Res 11(5):910\u2013923","journal-title":"Transl Stroke Res"},{"issue":"5","key":"5980_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052550","volume":"23","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Dong N, Hong H, Qi J, Zhang S, Wang J (2022) Mesenchymal stem cells: therapeutic mechanisms for stroke. Int J Mol Sci 23(5):2550","journal-title":"Int J Mol Sci"},{"key":"5980_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2024.102320","volume":"87","author":"DIN Pratiwi","year":"2024","unstructured":"Pratiwi DIN, Alhajlah S, Alawadi A, Hjazi A, Alawsi T, Almalki SG, Alsalamy A, Kumar A (2024) Mesenchymal stem cells and their extracellular vesicles as emerging therapeutic tools in the treatment of ischemic stroke. Tissue Cell 87:102320","journal-title":"Tissue Cell"},{"issue":"1","key":"5980_CR63","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41572-019-0118-8","volume":"5","author":"BCV Campbell","year":"2019","unstructured":"Campbell BCV, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, Davis SM et al (2019) Ischaemic stroke. Nat Rev Dis Primers 5(1):70","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"5980_CR64","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/0271678X211026770","volume":"42","author":"K Zheng","year":"2022","unstructured":"Zheng K, Lin L, Jiang W, Chen L, Zhang X, Zhang Q et al (2022) Single-cell RNA-seq reveals the transcriptional landscape in ischemic stroke. J Cereb Blood Flow Metab 42(1):56\u201373","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"5980_CR65","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjac077","volume":"14","author":"K Xue","year":"2023","unstructured":"Xue K, Qi M, She T, Jiang Z, Zhang Y, Wang X et al (2023) Argon mitigates post-stroke neuroinflammation by regulating M1\/M2 polarization and inhibiting NF-\u03baB\/NLRP3 inflammasome signaling. J Mol Cell Biol 14(12):mjac077","journal-title":"J Mol Cell Biol"},{"issue":"1","key":"5980_CR66","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12974-024-03086-8","volume":"21","author":"C Wu","year":"2024","unstructured":"Wu C, Zhang S, Sun H, Li A, Hou F, Qi L et al (2024) STING inhibition suppresses microglia-mediated synapses engulfment and alleviates motor functional deficits after stroke. J Neuroinflammation 21(1):86","journal-title":"J Neuroinflammation"},{"issue":"16","key":"5980_CR67","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3390\/cells13161401","volume":"13","author":"M Frydrychowicz","year":"2024","unstructured":"Frydrychowicz M, Telec M, Anio\u0142a J, Kazmierski R, Chowaniec H, Dworacki G et al (2024) The alteration of circulating invariant natural killer T, \u03b3\u03b4T, and natural killer cells after ischemic stroke in relation to clinical outcomes: a prospective case-control study. Cells 13(16):1401","journal-title":"Cells"},{"issue":"1","key":"5980_CR68","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s12967-025-06440-3","volume":"23","author":"W Lei","year":"2025","unstructured":"Lei W, Zhuang H, Huang W, Sun J (2025) Neuroinflammation and energy metabolism: a dual perspective on ischemic stroke. J Transl Med 23(1):413. https:\/\/doi.org\/10.1186\/s12967-025-06440-3","journal-title":"J Transl Med"},{"key":"5980_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136563","volume":"776","author":"X Dong","year":"2022","unstructured":"Dong X, Zhang X, Li C, Chen J, Xia S, Bao X et al (2022) \u03b3\u03b4 T cells aggravate blood-brain-barrier injury via IL-17A in experimental ischemic stroke. Neurosci Lett 776:136563","journal-title":"Neurosci Lett"},{"key":"5980_CR70","doi-asserted-by":"publisher","first-page":"1512634","DOI":"10.3389\/fimmu.2025.1512634","volume":"16","author":"Z Lian","year":"2025","unstructured":"Lian Z, Luo Y, Li Y, Gao Y, Xiong X, Gu L (2025) CD4+ T cells in ischemic stroke: effects and therapeutic targets. Front Immunol 16:1512634","journal-title":"Front Immunol"},{"key":"5980_CR71","doi-asserted-by":"publisher","unstructured":"Suda S, Nito C, Ihara M, Iguchi Y, Urabe T, Matsumaru Y, J-REPAIR Trial Group et al (2022) Randomised placebo-controlled multicentre trial to evaluate the efficacy and safety of JTR-161, allogeneic human dental pulp stem cells, in patients with acute ischaemic stroke (J-REPAIR). BMJ Open 12(5):e054269. https:\/\/doi.org\/10.1136\/bmjopen-2021-054269","DOI":"10.1136\/bmjopen-2021-054269"},{"key":"5980_CR72","unstructured":"Healios KK (2022) MultiStem administration for stroke treatment and enhanced recovery study (MASTERS-2). ClinicalTrials.gov. [cited 2026 Jan 18]"},{"key":"5980_CR73","unstructured":"Savitz S (2018) Safety of mesenchymal stromal cells for ischemic stroke (SAMCIS). ClinicalTrials.gov. [cited 2026 Jan 18]"},{"key":"5980_CR74","unstructured":"Meridigen Biotech Co., Ltd. (2025) The safety and tolerability after intravenous infusion of UMC119-06 in subjects with acute ischemic stroke. ClinicalTrials.gov. [cited 2026 Jan 18]"},{"key":"5980_CR75","unstructured":"Duan Lian, Academy of Military Medical Science, Beijing, China (2015) Cell therapy by intravenous injection of umbilical cord-derived mesenchymal stem cells after stroke. ClinicalTrials.gov. [cited 2026 Jan 18]"},{"key":"5980_CR76","unstructured":"Liem T Nguyen, Vinmec Research Institute of Stem Cell and Gene Technology Research. Outcomes of umbilical cord-derived mesenchymal stem cell infusion in patients with neurological sequelae after ischemic stroke. ClinicalTrials.gov. [cited 2026 Jan 18]"},{"key":"5980_CR77","unstructured":"Dehghani L (2021) Safety and efficacy of allogenic mesenchymal stem cell-derived exosome on disability of patients with acute ischemic stroke: a randomized, single-blind, placebo-controlled, phase 1\/2 trial. ClinicalTrials.gov. [cited 2026 Jan 18]"},{"key":"5980_CR78","unstructured":"Cytopeutics Sdn. Bhd. (2025) Cytopeutics: a phase II\/III double-blind randomized controlled study to assess the efficacy of umbilical cord mesenchymal stem cells (Neuroncell-EX) transplantation in patients with acute ischemic stroke. ClinicalTrials.gov. [cited 2026 Jan 18]"},{"key":"5980_CR79","unstructured":"Shanghai East Hospital (2023) Effect of human umbilical cord mesenchymal stem cells transplantation on prognosis of acute cerebral infarction patients. ClinicalTrials.gov. [cited 2026 Jan 18]"},{"key":"5980_CR80","unstructured":"Rima Haifa Prodia StemCell Indonesia (2026) Safety and efficacy of combined conditioned medium with umbilical cord mesenchymal stem cells as a novel strategy for acute stroke infarct. ClinicalTrials.gov. [cited 2026 Jan 18]"},{"key":"5980_CR81","unstructured":"Instituto de Investigaci\u00f3n Hospital Universitario La Paz (2023) Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke (AMASCIS-02). ClinicalTrials.gov. [cited 2026 Jan 18]"},{"key":"5980_CR82","unstructured":"Keith W Muir. University of Glasgow (2018) A phase II efficacy study of intracerebral CTX0E03 DP in patients with stable paresis of the arm following an ischaemic stroke. ClinicalTrials.gov. [cited 2026 Jan 18]"},{"issue":"16","key":"5980_CR83","doi-asserted-by":"publisher","first-page":"7928","DOI":"10.3390\/ijms26167928","volume":"26","author":"MP Iordache","year":"2025","unstructured":"Iordache MP, Buliman A, Costea-Firan C, Gligore TCI, Cazacu IS, Stoian M et al (2025) Immunological and inflammatory biomarkers in the prognosis, prevention, and treatment of ischemic stroke: a review of a decade of advancement. Int J Mol Sci 26(16):7928","journal-title":"Int J Mol Sci"},{"key":"5980_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.911661","volume":"13","author":"F Wu","year":"2022","unstructured":"Wu F, Liu Z, Zhou L, Ye D, Zhu Y, Huang K et al (2022) Systemic immune responses after ischemic stroke: from the center to the periphery. Front Immunol 13:911661","journal-title":"Front Immunol"},{"issue":"4","key":"5980_CR85","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14512","volume":"30","author":"X Wang","year":"2024","unstructured":"Wang X, Zhang S, Lv B, Chen H, Zhang W, Dong L et al (2024) Circular RNA PTP4A2 regulates microglial polarization through STAT3 to promote neuroinflammation in ischemic stroke. CNS Neurosci Ther 30(4):e14512","journal-title":"CNS Neurosci Ther"},{"key":"5980_CR86","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.reth.2024.03.026","volume":"27","author":"E Mo\u00f1ivas Gallego","year":"2024","unstructured":"Mo\u00f1ivas Gallego E, Zurita CM (2024) Mesenchymal stem cell therapy in ischemic stroke trials: a systematic review. Regen Ther 27:301\u2013306","journal-title":"Regen Ther"},{"issue":"2","key":"5980_CR87","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/stcltm\/szad080","volume":"13","author":"DT Laskowitz","year":"2024","unstructured":"Laskowitz DT, Troy J, Poehlein E, Bennett ER, Shpall EJ, Wingard JR et al (2024) A randomized, placebo-controlled, phase II trial of intravenous allogeneic non-HLA matched, unrelated donor cord blood infusion for ischemic stroke. Stem Cells Transl Med 13(2):125\u2013136","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"5980_CR88","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13287-025-04224-6","volume":"16","author":"S Chen","year":"2025","unstructured":"Chen S, Han C, Shi Z, Guan X, Cheng L, Wang L et al (2025) Umbilical mesenchymal stem cells mitigate T-cell compartment shifts and Th17\/Treg imbalance in acute ischemic stroke via mitochondrial transfer. Stem Cell Res Ther 16(1):134","journal-title":"Stem Cell Res Ther"},{"issue":"14","key":"5980_CR89","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S","volume":"17","author":"FY Hsieh","year":"1998","unstructured":"Hsieh FY, Bloch DA, Larsen MD (1998) A simple method of sample size calculation for linear and logistic regression. Stat Med 17(14):1623\u20131634. https:\/\/doi.org\/10.1002\/(SICI)1097-0258(19980730)17:14%3c1623::AID-SIM871%3e3.0.CO;2-S","journal-title":"Stat Med"},{"key":"5980_CR90","unstructured":"ICH Expert Working Group (1998) ICH harmonised tripartite guideline: statistical principles for clinical trials E9. International Conference on Harmonisation, Geneva. [cited 2026 Jan 18]"},{"issue":"7003","key":"5980_CR91","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1136\/bmj.311.7003.485","volume":"311","author":"DG Altman","year":"1995","unstructured":"Altman DG, Bland JM (1995) Absence of evidence is not evidence of absence. BMJ 311(7003):485. https:\/\/doi.org\/10.1136\/bmj.311.7003.485","journal-title":"BMJ"},{"issue":"2","key":"5980_CR92","doi-asserted-by":"publisher","first-page":"H184","DOI":"10.1152\/ajpheart.00328.2013","volume":"306","author":"CG McCarthy","year":"2014","unstructured":"McCarthy CG, Goulopoulou S, Wenceslau CF, Spitler K, Matsumoto T, Webb RC (2014) Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension. Am J Physiol Heart Circ Physiol 306(2):H184\u2013H196. https:\/\/doi.org\/10.1152\/ajpheart.00328.2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5980_CR93","unstructured":"Jiang JK, Walsh MJ, Brimacombe KR, Anastasiou D, Yu Y, Israelsen WJ et al (2010) ML265: a potent PKM2 activator induces tetramerization and reduces tumor formation and size in a mouse xenograft model. In: Probe Reports from the NIH Molecular Libraries Program. National Center for Biotechnology Information (US), Bethesda (MD). [cited 2026 Jan 18]"},{"issue":"3","key":"5980_CR94","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/ijs.12065","volume":"9","author":"DC Hess","year":"2014","unstructured":"Hess DC, Sila CA, Furlan AJ, Wechsler LR, Switzer JA, Mays RW (2014) A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke. Int J Stroke 9(3):381\u2013386","journal-title":"Int J Stroke"},{"issue":"3","key":"5980_CR95","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s13311-018-0635-2","volume":"15","author":"D Chen","year":"2018","unstructured":"Chen D, Wei L, Liu ZR, Yang JJ, Gu X, Wei ZZ et al (2018) Pyruvate kinase M2 increases angiogenesis, neurogenesis, and functional recovery mediated by upregulation of STAT3 and focal adhesion kinase activities after ischemic stroke in adult mice. Neurotherapeutics 15(3):770\u2013784","journal-title":"Neurotherapeutics"},{"key":"5980_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115231","volume":"163","author":"J Wang","year":"2025","unstructured":"Wang J, Cai W, Yang G, Liang R, Wang Z, Li S et al (2025) Micheliolide interferes with PKM2-p65 interaction and inhibits inflammasome activation in macrophages after ischemic stroke. Int Immunopharmacol 163:115231","journal-title":"Int Immunopharmacol"},{"key":"5980_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.714943","volume":"12","author":"H Zhu","year":"2021","unstructured":"Zhu H, Jian Z, Zhong Y, Ye Y, Zhang Y, Hu X et al (2021) Janus kinase inhibition ameliorates ischemic stroke injury and neuroinflammation through reducing NLRP3 inflammasome activation via JAK2\/STAT3 pathway inhibition. Front Immunol 12:714943","journal-title":"Front Immunol"},{"key":"5980_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2023.114474","volume":"368","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xu M, Chen F, Su Y, Yu M, Xing L et al (2023) Targeting the JAK2-STAT3 pathway to inhibit cGAS-STING activation improves neuronal senescence after ischemic stroke. Exp Neurol 368:114474","journal-title":"Exp Neurol"},{"issue":"5","key":"5980_CR99","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S1474-4422(17)30046-7","volume":"16","author":"DC Hess","year":"2017","unstructured":"Hess DC, Wechsler LR, Clark WM, Savitz SI, Ford GA, Chiu D et al (2017) Safety and efficacy of multipotent adult progenitor cells in acute ischemic stroke (MASTERS): a randomized, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol 16(5):360\u2013368","journal-title":"Lancet Neurol"},{"issue":"8","key":"5980_CR100","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1212\/WNL.57.8.1428","volume":"57","author":"Enlimomab Acute Stroke Trial Investigators","year":"2001","unstructured":"Enlimomab Acute Stroke Trial Investigators (2001) Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology 57(8):1428\u20131434","journal-title":"Neurology"},{"issue":"4","key":"5980_CR101","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3390\/cells10040767","volume":"10","author":"C Davis","year":"2021","unstructured":"Davis C, Savitz SI, Satani N (2021) Mesenchymal stem cell derived extracellular vesicles for repairing the neurovascular unit after ischemic stroke. Cells 10(4):767. https:\/\/doi.org\/10.3390\/cells10040767","journal-title":"Cells"},{"issue":"1","key":"5980_CR102","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1038\/s41467-025-58254-y","volume":"16","author":"X Zhang","year":"2025","unstructured":"Zhang X, Li H, Gu Y, Ping A, Chen J, Zhang Q et al (2025) Repair-associated macrophages increase after early-phase microglia attenuation to promote ischemic stroke recovery. Nat Commun 16(1):3089. https:\/\/doi.org\/10.1038\/s41467-025-58254-y","journal-title":"Nat Commun"},{"key":"5980_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2026.101172","volume":"52","author":"A Papageorgiou","year":"2026","unstructured":"Papageorgiou A, Chatzistefanidis D, Nikolakea M, Karela NR, Gkrampovari M, Lantavos K et al (2026) The emerging role of lymphocytes in post-stroke inflammation: a treatable target and review of current pharmacological evidence in humans. Brain Behav Immun Health 52:101172. https:\/\/doi.org\/10.1016\/j.bbih.2026.101172","journal-title":"Brain Behav Immun Health"},{"issue":"1","key":"5980_CR104","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70248","volume":"31","author":"N Li","year":"2025","unstructured":"Li N, Wang H, Hu C, Qie S, Liu Z (2025) Regulatory T cells for stroke recovery: a promising immune therapeutic strategy. CNS Neurosci Ther 31(1):e70248","journal-title":"CNS Neurosci Ther"},{"issue":"12","key":"5980_CR105","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1002\/sim.1783","volume":"23","author":"SA Julious","year":"2004","unstructured":"Julious SA (2004) Sample sizes for clinical trials with normal data. Stat Med 23(12):1921\u20131986. https:\/\/doi.org\/10.1002\/sim.1783","journal-title":"Stat Med"},{"issue":"10","key":"5980_CR106","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41573-019-0034-3","volume":"18","author":"APT Coalition","year":"2019","unstructured":"Coalition APT (2019) Adaptive platform trials: definition, design, conduct, and reporting considerations. Nat Rev Drug Discov 18(10):797\u2013807. https:\/\/doi.org\/10.1038\/s41573-019-0034-3","journal-title":"Nat Rev Drug Discov"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05980-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05980-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05980-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:07:12Z","timestamp":1781824032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05980-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5980"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05980-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable; this systematic review does not involve the collection of new human participant data, human tissue, or animal data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable; this manuscript does not contain any individual person\u2019s data in any form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"703"}}